Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort

AIDS

Volumn 17, Issue 17, 2003, Pages 2521-2527

  Brodine, Stephanie K ^a,b   Starkey, Monica J ^b,c   Shaffer, Richard A ^a,b   Ito, Stanley I ^b,d   Tasker, Sybil A ^b,e   Barile, Anthony J ^f   Tamminga, Cindy L ^g   Stephan, Kevin T ^h   Aronson, Naomi E ^e,f,i   Fraser, Susan L ^j   Wallace, Mark R ^b   Wegner, Scott A ^e   Mascola, John R ^e,k   McCutchan, Francine E ^c  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^h WILFORD HALL MEDICAL CENTER   (United States)

ⁱ UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^j BROOKE ARMY MEDICAL CENTER   (United States)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

Cross sectional study; Epidemiology; HIV 1; Hiv 1 subtypes; Risk factors; Seroconversion; US military

Indexed keywords

CD4 ANTIGEN;

ADULT; AGED; ARMY; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; HEALTH BEHAVIOR; HEPATITIS B; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEROCONVERSION; SERODIAGNOSIS; SEXUAL BEHAVIOR; SYPHILIS; UNITED STATES; VIRUS IDENTIFICATION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PREVALENCE; RISK-TAKING; SEXUAL BEHAVIOR; UNITED STATES;

EID: 12144290937     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200311210-00016     Document Type: Article

References (30)

1. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342:921-929.
2. Flanigan T, Tashima, KT. Diagnosis of acute HIV infection: it's time to get moving! Ann Intern Med 2001, 134:75-77.
3. Cates W, Jr, Chesney MA, Cohen MS. Primary HIV infection: a public health opportunity. Am J Public Health 1997, 87: 1928-1930.
4. Phillips S, Granade TC, Pau CP, Candal D, Hu DJ, Parekh BS. Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clin Diagn Lab Immunol 2000, 7:698-699.
5. Koch W, Sullivan P, Roberts C, Downing R, Mastro TD. Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants. J Clin Microbiol 2001, 39:1017-1020.
6. Wegner SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, et al. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel. AIDS 2000, 14: 1009-1015.
7. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999, 131:502-506.
8. McCutchan FE. Global diversity in HIV In: The Evolution of HIV. Edited by Crandall KA. Baltimore, MD: Johns Hopkins University Press; 1999:41-101.
9. Gaywee J, Artenstein A, van Cott T, Trichavaroj R, Sukchamnong, Amlee P, et al. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:392-396.
10. Vahey M, Nau ME, Barrick S, Cooley J, Vickerman P, Larder B, et al. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol 1999, 37:2533-2537.
11. Quinn TC. Acute primary HIV infection. JAMA 1997, 278: 58-62.
12. Sullivan PS, Do AN, Ellenberger D, Pau C, Paul S, Robbins K, et al. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States. J Infect Dis 2000, 181: 463-469.
13. Weidle PJ, Ganea CE, Irwin KL, Pieniazek D, McGowan JP, Olivo N, et al. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis 2000, 181:470-475.
14. McCutchan F. Understanding the genetic diversity of HIV-1. AIDS 2000, 14:S31-S44.
15. Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga C, et al. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. AIDS 1999, 13:1613-1621.
16. Yahi N, Fantini J, Tourres C, Tivoli N, Koch N, Tamalet C. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J Infect Dis 2001, 183: 1311-1317.
17. Gonzales M, Machekano R, Shafer R. Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J Infect Dis 2001, 184:998-1006.
18. Michael N, Louie L, Rohrbaugh A, Schultz KA, Dayhoff DE, Wang CE, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997, 3:1160-1162.
19. Alaeus A, Lilja E, Herman S, Spadoro J, Wang J, Albert J. Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the Amplicor HIV-1 monitor assay. AIDS Res Hum Retroviruses 1999, 15:889-894.
20. Walter E, Gilliam B, Delmar J, Spooner K, Morris JT, Aronson N, et al. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection. Clin Infect Dis 2000, 31:798-802.
21. Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, et al. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998, 14:319-327.
22. Paladin F, Monzon O, Tsuchie H, Aplasca M, Learn GJ, Kurimura T. Genetic subtypes of HIV-1 in the Philippines. AIDS 1998, 12:291-300.
23. Robertson D, Anderson J, Bradac J, Carr JK, Foley B, Funkhouser RK, et al. HIV-1 nomenclature proposal. Science 2000, 288: 55-57.
24. Carr J, Torimiro J, Wolfe N, Eitel M, Kim B, Sanders-Buell E, et al. The AG recombinant IBNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001, 286:168-181.
25. Cornelissen M, van den Burg R, Zorgdrager F, Goudsmit J. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J Gen Virol 2000, 81:515-523.
26. Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis 2002, 186:486-492.
27. Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young N, Mock P, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001, 15:683-691.
28. Tatt ID, Barlow KL, Nicoll A, Clewley JP. The public health significance of HIV-1 subtypes. AIDS 2001, 15(Suppl. 5): S59-S71.
29. Brodine S, Mascola J, McCutchan F. Genotypic variation and molecular epidemiology of HIV. Infect Med 1997, 14:739-748.
30. Boyer C, Shafer M, Shaffer R, Brodine S, Ito S, Yniguez DL, et al. Prevention of sexually transmitted diseases and HIV in young military men: evaluation of a cognitive-behavioral skills-building intervention. Sex Transm Dis 2001, 28:349-355.